KR100983953B1 - 신생 골의 형성을 유도하기 위한 탄소-2-개질된 19-노르-비타민 d 유사체의 용도 - Google Patents
신생 골의 형성을 유도하기 위한 탄소-2-개질된 19-노르-비타민 d 유사체의 용도 Download PDFInfo
- Publication number
- KR100983953B1 KR100983953B1 KR1020047015427A KR20047015427A KR100983953B1 KR 100983953 B1 KR100983953 B1 KR 100983953B1 KR 1020047015427 A KR1020047015427 A KR 1020047015427A KR 20047015427 A KR20047015427 A KR 20047015427A KR 100983953 B1 KR100983953 B1 KR 100983953B1
- Authority
- KR
- South Korea
- Prior art keywords
- group
- compound
- pharmaceutical composition
- bone
- vitamin
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
Abstract
Description
Claims (28)
- 치료상 유효량의 하기 화학식 I로 표현되는 화합물을 포함하는, 포유류에서 신생 골의 증식을 자극함에 의하여, 골절의 치유 촉진, 골이식의 치유 촉진, 골이식물의 고형화 촉진, 치아 이식물의 골결합 촉진, 치주골 증식 촉진 또는 골신장술 (distraction osteogenesis) 과정 후 골 재질의 개선을 위한 제약 조성물.<화학식 I>식 중, Y1 및 Y2는 동일하거나 상이할 수 있으며 각각 수소, 및 알콕시카르보닐, 아실, 알킬실릴, 알킬아릴실릴기 또는 알콕시알킬기로부터 선택된 히드록시-보호기로 이루어진 군으로부터 선택되고, R11 및 R12는 각각 수소이거나 또는 함께 메틸렌기이고, R6 및 R7은 동일하거나 상이할 수 있으며 각각 수소, 알킬, 히드록시알킬, 플루오로알킬, 히드록시 및 알콕시로 이루어진 군으로부터 선택되되, 단, R6 및 R7은 둘 다 수소일 수 없거나, 또는 R6 및 R7은 함께 -(CH2)x-기 (X는 2 내지 5의 정수임)를 나타낼 수 있거나, 또는 R6 및 R7은 함께 =CR8R9기 (R8 및 R9는 동일하거나 상이할 수 있으며 각각 수소, 알킬, 히드록시알킬, 플루오로알킬, 히드록시 및 알콕시로 이루어진 군으로부터 선택되거나, 또는 R8 및 R9는 함께 -(CH2)x-기 (X는 2 내지 5의 정수임)를 나타낼 수 있음)를 나타낼 수 있고, R기는 하기의 기 중 어느 하나를 나타낸다:식 중, 입체화학 중심 (스테로이드 넘버링에서 C-20에 해당)은 R 또는 S 배열 (즉, 20번 탄소 주위에서 천연 배위 또는 20-에피 배위)를 가질 수 있다.
- 제1항에 있어서, 구강 투여용, 비경구 투여용, 경피 투여용 또는 국소 투여용인 제약 조성물.
- 제1항에 있어서, 신생 골 증식이 요구되는 부위에 고정 형태로 투여되는 제약 조성물.
- 제1항에 있어서, 신생 골 증식이 요구되는 부위에 서방 형태로 투여되는 제약 조성물.
- 제1항에 있어서, 상기 화합물이 조성물 내에 0.01 ㎍/g 내지 50 ㎍/g의 양으로 존재하는 것인 제약 조성물.
- 제1항에 있어서, 포유류가 사람인 제약 조성물.
- 제1항에 있어서, 투여되는 화합물이 하기 화학식으로 표현되는 아실화 유도체인 제약 조성물.식 중, Y1 및 Y2는 독립적으로 수소 또는 아실기를 나타내되, 단, R5는 -OY3이고, Y3은 아실 또는 히드로카르빌옥시카르보닐로 이루어진 군으로부터 선택된다.
- 제8항에 있어서, 상기 화합물이, Y1, Y2 및 Y3이 각각 CH3CO-인 트리아세테이트인 제약 조성물.
- 제8항에 있어서, 상기 화합물이, Y1, Y2 및 Y3이 각각 CH3(CH2)4CO-인 트리헥사노에이트인 제약 조성물.
- 제8항에 있어서, 상기 화합물이, Y1, Y2 및 Y3이 각각 CH3(CH2)7CO-인 트리노나노에이트인 제약 조성물.
- 제8항에 있어서, 상기 화합물이, Y1 및 Y2가 둘 다 수소이고, Y3이 CH3CO-인 25-아세테이트인 제약 조성물.
- 제8항에 있어서, 상기 화합물이 2-메틸렌-19-노르-1α,25(OH)2-D3-1,3,25-트리아세테이트, 2-메틸렌-19-노르-1α,25(OH)2-D3-1,3,25-트리헥사노에이트, 2-메틸렌-19-노르-1α,25(OH)2-D3-1,3,25-트리노나노에이트 및 2-메틸렌-19-노르-1α,25(OH)2-D3-25-아세테이트로 이루어진 군으로부터 선택된 것인 제약 조성물.
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/105,826 | 2002-03-25 | ||
US10/105,826 US20030195175A1 (en) | 2002-03-25 | 2002-03-25 | Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone |
PCT/US2003/007443 WO2003082300A1 (en) | 2002-03-25 | 2003-03-12 | Use of carbon-2-modified-vitamin d analogs to induce the formation of new bone |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040095346A KR20040095346A (ko) | 2004-11-12 |
KR100983953B1 true KR100983953B1 (ko) | 2010-09-27 |
Family
ID=28673538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020047015427A KR100983953B1 (ko) | 2002-03-25 | 2003-03-12 | 신생 골의 형성을 유도하기 위한 탄소-2-개질된 19-노르-비타민 d 유사체의 용도 |
Country Status (20)
Country | Link |
---|---|
US (3) | US20030195175A1 (ko) |
EP (1) | EP1494680B1 (ko) |
JP (1) | JP2005527558A (ko) |
KR (1) | KR100983953B1 (ko) |
CN (1) | CN100531739C (ko) |
AT (1) | ATE406901T1 (ko) |
AU (1) | AU2003220169B2 (ko) |
BR (1) | BR0308701A (ko) |
CA (1) | CA2480125C (ko) |
DE (1) | DE60323351D1 (ko) |
DK (1) | DK1494680T3 (ko) |
ES (1) | ES2312764T3 (ko) |
HK (1) | HK1079996B (ko) |
IL (1) | IL164275A0 (ko) |
MX (1) | MXPA04009288A (ko) |
NZ (1) | NZ535843A (ko) |
PL (1) | PL372346A1 (ko) |
PT (1) | PT1494680E (ko) |
WO (1) | WO2003082300A1 (ko) |
ZA (1) | ZA200408153B (ko) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007505884A (ja) * | 2003-09-19 | 2007-03-15 | ファイザー・プロダクツ・インク | 骨減少症又は男性の骨粗しょう症の治療のための2−アルキリデン−19−ノル−ビタミンd誘導体 |
WO2005027919A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | 2-alkylidene-19-nor-vitamin d derivatives for the treatment of a second hip fracture |
EP1667688A1 (en) * | 2003-09-19 | 2006-06-14 | Pfizer Products Inc. | 2-alkylidene-19-nor-vitamin d derivatives for the treatment of frailty, muscle damage or sarcopenia |
AU2004273658A1 (en) * | 2003-09-19 | 2005-03-31 | Wisconsin Alumni Research Foundation (Warf) | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an estrogen agonist/antagonist |
WO2005027928A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | 2-alkylidene-19-nor-vit amin d derivatives for the treatment of hypocalcemic tetany or hyproparathyroidism |
US7214671B2 (en) * | 2004-02-19 | 2007-05-08 | Wisconsin Alumni Research Foundation | Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 for the prophylaxis of bone diseases |
WO2005111197A1 (en) * | 2004-05-07 | 2005-11-24 | Wisconsin Alumni Research Foundation | Method of forming mesenchymal stem cells from embryonic stem cells |
WO2006061683A1 (en) * | 2004-12-09 | 2006-06-15 | Pfizer Products Inc. | 2-alkylidene-19-nor-vitamin d derivatives for the treatment of osteogenesis imperfecta |
US7803789B2 (en) * | 2006-02-02 | 2010-09-28 | Wisconsin Alumni Research Foundation | Vitamin D analog—RAK, methods and uses thereof |
US7528122B2 (en) | 2006-02-02 | 2009-05-05 | Wisconsin Alumni Research Foundation | Vitamin D analog—NEL, methods and uses thereof |
US20120115824A1 (en) * | 2009-04-17 | 2012-05-10 | Vidasym, Llc | Vitamin D Receptor Agonists and Uses Thereof |
WO2017023617A1 (en) * | 2015-08-05 | 2017-02-09 | Wisconsin Alumni Research Foundation | Synthesis and biological activity of 2-methylene analogs of calcitriol and related compounds |
CN111588506B (zh) * | 2020-01-02 | 2022-01-25 | 南京医科大学 | 一种含维生素c的钛种植体存储液的应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998041501A1 (en) * | 1997-03-17 | 1998-09-24 | Wisconsin Alumni Research Foundation | 2-alkylidene-19-nor-vitamin d compounds |
WO2002005823A2 (en) * | 2000-07-14 | 2002-01-24 | Wisconsin Alumni Research Foundation | USE OF 2-METHYLENE-19-NOR-20(S)-1α,25-DIHYDROXYVITAMIN D3 TO INCREASE BONE STRENGTH |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US584928A (en) * | 1897-06-22 | Schlag | ||
US4666634A (en) * | 1984-12-05 | 1987-05-19 | Chugai Seiyaku Kabushiki Kaisha | vitamin D3 derivatives having a substituent at 2-position |
IL74617A (en) * | 1985-03-15 | 1988-11-15 | Yeda Res & Dev | Compositions comprising a vitamin d derivative and method for the local treatment of bone fractures in animals |
US5246925A (en) * | 1989-03-09 | 1993-09-21 | Wisconsin Alumni Research Foundation | 19-nor-vitamin D compounds for use in treating hyperparathyroidism |
CA1333616C (en) * | 1989-03-09 | 1994-12-20 | Hector F. Deluca | 19-nor-vitamin d compounds |
US5556645A (en) * | 1990-01-12 | 1996-09-17 | Bockman; Richard | Methods of enhancing wound healing and tissue repair |
US5086191A (en) * | 1991-05-28 | 1992-02-04 | Wisconsin Alumni Research Foundation | Intermediates for the synthesis of 19-nor vitamin D compounds |
DE69400495T2 (de) * | 1993-04-05 | 1997-04-30 | Wisconsin Alumni Res Found | 19-Nor-vitamin-D3-Verbindung mit einem Substituent an die 2. Stelle |
US5565589A (en) * | 1993-11-03 | 1996-10-15 | Wisconsin Alumni Research Foundation | 17-formyl-5,6-trans-vitamin D compounds |
US5428029A (en) * | 1993-11-24 | 1995-06-27 | Hoffmann-La Roche Inc. | Vitamin D3 fluorinated analogs |
WO1997011053A1 (en) * | 1995-09-21 | 1997-03-27 | Wisconsin Alumni Research Foundation | Calcitriol derivatives and their uses |
US5976142A (en) * | 1996-10-16 | 1999-11-02 | Chin; Martin | Apparatus and method for distraction osteogenesis of small alveolar bone |
US5945410A (en) * | 1997-03-17 | 1999-08-31 | Wisconsin Alumni Research Foundation | 2-alkyl-19-nor-vitamin D compounds |
US6306844B1 (en) * | 1997-03-17 | 2001-10-23 | Wisconsin Alumni Research Foundation | Use of 2α-methyl-19-nor-20(S)-1α, 25-dihydroxyvitamin D3 to increase bone strength |
US6392071B1 (en) * | 1997-03-17 | 2002-05-21 | Wisconsin Alumni: Research Foundation | 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds |
WO1999006563A1 (en) * | 1997-07-30 | 1999-02-11 | Emory University | Novel bone mineralization proteins, dna, vectors, expression systems |
-
2002
- 2002-03-25 US US10/105,826 patent/US20030195175A1/en not_active Abandoned
-
2003
- 2003-03-12 KR KR1020047015427A patent/KR100983953B1/ko active IP Right Grant
- 2003-03-12 WO PCT/US2003/007443 patent/WO2003082300A1/en active Application Filing
- 2003-03-12 ES ES03716465T patent/ES2312764T3/es not_active Expired - Lifetime
- 2003-03-12 IL IL16427503A patent/IL164275A0/xx not_active IP Right Cessation
- 2003-03-12 CN CNB038119684A patent/CN100531739C/zh not_active Expired - Fee Related
- 2003-03-12 DE DE60323351T patent/DE60323351D1/de not_active Expired - Lifetime
- 2003-03-12 MX MXPA04009288A patent/MXPA04009288A/es active IP Right Grant
- 2003-03-12 US US10/509,065 patent/US20050203071A1/en not_active Abandoned
- 2003-03-12 CA CA002480125A patent/CA2480125C/en not_active Expired - Fee Related
- 2003-03-12 BR BR0308701-8A patent/BR0308701A/pt not_active Application Discontinuation
- 2003-03-12 AT AT03716465T patent/ATE406901T1/de active
- 2003-03-12 PT PT03716465T patent/PT1494680E/pt unknown
- 2003-03-12 AU AU2003220169A patent/AU2003220169B2/en not_active Ceased
- 2003-03-12 DK DK03716465T patent/DK1494680T3/da active
- 2003-03-12 JP JP2003579837A patent/JP2005527558A/ja active Pending
- 2003-03-12 EP EP03716465A patent/EP1494680B1/en not_active Expired - Lifetime
- 2003-03-12 NZ NZ535843A patent/NZ535843A/xx not_active IP Right Cessation
- 2003-03-12 PL PL03372346A patent/PL372346A1/xx unknown
-
2004
- 2004-10-08 ZA ZA200408153A patent/ZA200408153B/xx unknown
-
2006
- 2006-01-04 HK HK06100147.6A patent/HK1079996B/zh not_active IP Right Cessation
-
2010
- 2010-12-02 US US12/958,879 patent/US20110112056A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998041501A1 (en) * | 1997-03-17 | 1998-09-24 | Wisconsin Alumni Research Foundation | 2-alkylidene-19-nor-vitamin d compounds |
WO2002005823A2 (en) * | 2000-07-14 | 2002-01-24 | Wisconsin Alumni Research Foundation | USE OF 2-METHYLENE-19-NOR-20(S)-1α,25-DIHYDROXYVITAMIN D3 TO INCREASE BONE STRENGTH |
Also Published As
Publication number | Publication date |
---|---|
AU2003220169A1 (en) | 2003-10-13 |
US20030195175A1 (en) | 2003-10-16 |
PT1494680E (pt) | 2008-10-21 |
HK1079996B (zh) | 2010-04-01 |
CN100531739C (zh) | 2009-08-26 |
DE60323351D1 (de) | 2008-10-16 |
HK1079996A1 (en) | 2006-04-21 |
CA2480125C (en) | 2009-12-29 |
DK1494680T3 (da) | 2008-11-17 |
WO2003082300A1 (en) | 2003-10-09 |
JP2005527558A (ja) | 2005-09-15 |
CN1655797A (zh) | 2005-08-17 |
US20110112056A1 (en) | 2011-05-12 |
ZA200408153B (en) | 2006-03-29 |
EP1494680B1 (en) | 2008-09-03 |
KR20040095346A (ko) | 2004-11-12 |
EP1494680A1 (en) | 2005-01-12 |
PL372346A1 (en) | 2005-07-11 |
BR0308701A (pt) | 2005-01-18 |
US20050203071A1 (en) | 2005-09-15 |
CA2480125A1 (en) | 2003-10-09 |
AU2003220169B2 (en) | 2008-09-11 |
IL164275A0 (en) | 2005-12-18 |
ES2312764T3 (es) | 2009-03-01 |
NZ535843A (en) | 2006-03-31 |
ATE406901T1 (de) | 2008-09-15 |
MXPA04009288A (es) | 2005-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20110112056A1 (en) | Use of Carbon-2-Modified-Vitamin D Analogs to Induce the Formation of New Bone | |
AU2001275445B2 (en) | 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications | |
AU2001273303B8 (en) | Use of 2alpha-methyl-19-nor-20(s)-1alpha,25-dihydroxyvitamin D3 to increase bone strength | |
KR100835456B1 (ko) | 비타민 d 화합물의 투여량 범위를 확장시키는 방법 | |
US7115594B2 (en) | Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 to increase bone strength | |
AU2008289026A1 (en) | A method of extending the dose range of vitamin D compounds | |
AU2004316404B2 (en) | Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 for the prophylaxis of bone diseases | |
WO2005027915A1 (en) | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone | |
US5962707A (en) | 19-nor-vitamin D3 compounds with calcemic activity | |
US5696103A (en) | Method for treating osteoporosis | |
AU2002360534A1 (en) | 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130820 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20140825 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20150819 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20160818 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20170818 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20180816 Year of fee payment: 9 |